Frankfurt - Delayed Quote EUR

Clover Health Investments, Corp. (7QD.F)

Compare
2.9770 +0.0450 (+1.53%)
At close: December 20 at 3:29:01 PM GMT+1
Loading Chart for 7QD.F
DELL
  • Previous Close 2.9320
  • Open 2.9930
  • Bid 3.0410 x --
  • Ask 3.1750 x --
  • Day's Range 2.9770 - 2.9930
  • 52 Week Range 0.5720 - 4.0490
  • Volume 1,650
  • Avg. Volume 342
  • Market Cap (intraday) 1.545B
  • Beta (5Y Monthly) 2.04
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1800
  • Earnings Date Mar 10, 2025 - Mar 14, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

www.cloverhealth.com/en/

552

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 7QD.F

View More

Performance Overview: 7QD.F

Trailing total returns as of 12/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

7QD.F
244.32%
S&P 500
24.34%

1-Year Return

7QD.F
236.76%
S&P 500
24.38%

3-Year Return

7QD.F
13.71%
S&P 500
28.36%

5-Year Return

7QD.F
72.08%
S&P 500
85.03%

Compare To: 7QD.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7QD.F

View More

Valuation Measures

As of 12/20/2024
  • Market Cap

    1.54B

  • Enterprise Value

    1.23B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.72

  • Price/Book (mrq)

    4.58

  • Enterprise Value/Revenue

    0.61

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.32%

  • Return on Assets (ttm)

    -5.66%

  • Return on Equity (ttm)

    -28.90%

  • Revenue (ttm)

    2.12B

  • Net Income Avi to Common (ttm)

    -95.94M

  • Diluted EPS (ttm)

    -0.1800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    333.05M

  • Total Debt/Equity (mrq)

    1.07%

  • Levered Free Cash Flow (ttm)

    103.22M

Research Analysis: 7QD.F

View More